Breaking News, Promotions & Moves

NeuroCog Trials Adds to Leadership Team

With over 25 years experience, Dr. Kathleen Anne Welsh-Bohmer joins as vice president of Neurodegenerative Disorders

NeuroCog Trials (NCT) announced a major appointment on their scientific leadership team. Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimer’s Disease research, has joined as the vice president of Neurodegenerative Disorders. In her new role she will lead the development of new technology and tools to support customers conducting clinical trials for dementia and other cognitive disorders.   Having dedicated more than 25 years to research surrounding neurodegenerative disorders that occur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters